Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease

E-ISSN： 1873-4294|15|10|908-926

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.10, 2015-05, pp. : 908-926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine D Receptor Agonists: The Way Forward for the Treatment of Parkinson's Disease?

By Vermeulen R.J. Drukarch B. Wolters E.C. Stoof J.C.

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo Ceravolo Roberto

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite

Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?

By Stocchi F.

CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 159-170

Adis International

Access to resources Recommend Favorite

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 345-353

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron Jankovic Joseph

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite